RAMM Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	-8.65	-8.91	-16.5	-7.72	-20.96	-7.11
Depreciation & Amortization	0.61	0.73	1.21	1.34	1	0.72
Other Amortization	0	0	0	-	0.02	0.02
Loss (Gain) From Sale of Assets	-0.98	-0.77	-	-	-	-0.03
Asset Writedown & Restructuring Costs	4.77	4.77	7.56	1.07	13.18	-
Loss (Gain) From Sale of Investments	-	-	-	-	0.23	-0.27
Loss (Gain) on Equity Investments	-	-	-	-	-	0.71
Stock-Based Compensation	-	-	0.17	0.01	0.38	0.7
Provision & Write-off of Bad Debts	-0.01	0.01	-0.06	-0.01	0.07	0.1
Other Operating Activities	0.3	0.44	2.16	1.34	0.09	0.34
Change in Accounts Receivable	1.49	1.08	0.4	0.51	1.51	-0.22
Change in Inventory	0.75	1.02	0.58	-0.33	-0.09	0.51
Change in Accounts Payable	0.57	0.57	0.49	-0.54	-1.34	0.69
Change in Income Taxes	0	-0	0	-	-0	0
Operating Cash Flow	-1.14	-1.06	-4	-4.34	-5.91	-3.83
Capital Expenditures	0.03	-	-0.05	-0.06	-0.17	-0.43
Sale of Property, Plant & Equipment	1.76	1.22	-	0.15	0.04	0.03
Cash Acquisitions	-	-	-	-	-1.11	3.31
Investment in Securities	-	-	-	-	-	-10
Other Investing Activities	-	-	-	0.04	0.09	0.26
Investing Cash Flow	1.79	1.22	-0.05	0.13	-1.15	-6.83
Long-Term Debt Repaid	-	-0.15	-0.26	-0.29	-0.13	-0.08
Net Debt Issued (Repaid)	-0.1	-0.15	-0.26	-0.29	-0.13	-0.08
Repurchase of Common Stock	-	-	-	-0.17	-0.22	-0.09
Other Financing Activities	-0.01	-0.01	-	-	-	-
Financing Cash Flow	-0.11	-0.15	-0.26	-0.46	-0.35	-0.18
Foreign Exchange Rate Adjustments	-0.04	-0.01	0	0.01	0.04	-0.01
Net Cash Flow	0.5	-0.01	-4.3	-4.66	-7.38	-10.85
Free Cash Flow	-1.11	-1.06	-4.05	-4.4	-6.08	-4.26
Free Cash Flow Margin	-43.32%	-31.54%	-93.17%	-86.87%	-156.02%	-103.52%
Free Cash Flow Per Share	-0.01	-0.01	-0.03	-0.04	-0.05	-0.04
Cash Interest Paid	0.25	0.25	0.04	-	-	-
Cash Income Tax Paid	0.02	0.02	0.01	-	-	-
Levered Free Cash Flow	1.04	1.03	-2.86	-2.31	-3.79	-5.03
Unlevered Free Cash Flow	1.19	1.18	-2.84	-2.28	-3.79	-5.02
Change in Working Capital	2.81	2.67	1.47	-0.37	0.08	0.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.